Scisparc: mitocarex reveals promising results with discovery of novel anti-cancer small molecule structure

Mitocarex bio dedicates efforts to creating a predictive ai model to predict small molecules more efficiently tel aviv, israel, march 12, 2024 (globe newswire) -- scisparc ltd. (nasdaq: sprc) ("company" or "scisparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that mitocarex bio ltd.
SPRC Ratings Summary
SPRC Quant Ranking